Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05741229
Status:
RECRUITING
Last Update Posted:
2024-01-31
First Post:
2023-02-14
Brief Title:
The Effect of Nebulizied Nitroglycerin As an Adjuvant Therapy for Persistent Pulmonary Hypertension of Newborns
Sponsor:
Alexandria University
Organization:
Alexandria University
Study Overview
Official Title:
The Effect of Nebulizied Nitroglycerin As an Adjuvant Drug in Management of Persistent Pulmonary Hypertension of Newborns
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This aim of the study is to evaluate the effect of nebulized nitroglycerin on echocardiographic biventricular function pulmonary artery pressure PDA and PFO shunting and tissue doppler imaging and clinical parameters Oxygen saturation index heart rate blood pressure mean airway pressure ventilation setting in patients with PPHN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None